Fennec Pharmaceuticals Inc. (TSE:FRX – Get Rating) – Equities researchers at HC Wainwright cut their Q1 2023 EPS estimates for Fennec Pharmaceuticals in a research note issued to investors on Tuesday, April 4th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical company will post earnings of ($0.27) per share for the quarter, down […]
Fennec Pharmaceuticals Inc. (TSE:FRX – Get Rating) – Equities research analysts at Wedbush boosted their FY2024 earnings estimates for Fennec Pharmaceuticals in a research note issued to investors on Thursday, March 30th. Wedbush analyst D. Nierengarten now expects that the biopharmaceutical company will post earnings of $0.20 per share for the year, up from their […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Rating) was the recipient of a large decrease in short interest during the month of June. As of June 30th, there was short interest totalling 157,600 shares, a decrease of 25.4% from the June 15th total of 211,400 shares. Based on an average trading volume of 28,900 shares, the […]